The Discounted Cash Flow (DCF) valuation of Evofem Biosciences Inc (EVFM) is (624.19) USD. With the latest stock price at 0.48 USD, the upside of Evofem Biosciences Inc based on DCF is -130629.4%.
Based on the latest price of 0.48 USD and our DCF valuation, Evofem Biosciences Inc (EVFM) is a sell. selling EVFM stocks now will result in a potential gain of 130629.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.1% - 7.5% | 5.8% |
| Long-term Growth Rate | 3.0% - 3.8% | 3.4% |
| Fair Price | (5,622.06) - (345.14) | (624.19) |
| Upside | -1175771.9% - -72274.9% | -130629.4% |